Final Thoughts on Strategies for Managing and Monitoring Patients Receiving Teplizumab
The panel concludes its discussion with key takeaways on the optimal care of patients with type 1 diabetes care and thoughts on unmet needs within the treatment space.
Focusing on logistical matters as it pertains to teplizumab administration, the panel discusses infusion site considerations, insurance coverage hurdles, and the process of getting patients approved.
Teplizumab Infusion Protocol: Details on the 14-Day Process and Comprehensive Monitoring Overview
Diabetes specialists outline the patient selection protocol for teplizumab and describe the teplizumab infusion process.
Exploring Screening and Real-World Use of Teplizumab: Practical Insights and Clinical Experiences
Experts on type 1 diabetes discuss the availability of local medical facilities that offer teplizumab screening and evaluation services for individuals at risk of progression of disease.
TN-10 Study Analysis: Expert Perspectives on Key Efficacy and Safety Data
Amy Burton, MD, reviews findings from the TN-10 study investigating teplizumab, an anti-CD3 monoclonal antibody, for prevention of diabetes in relatives at risk for T1D.
Role of Teplizumab: First Approved Treatment for Delaying T1D Stage Progression
Diabetes experts discuss the important role of teplizumab in delaying the onset of type 1 diabetes and provide insights on the drug’s mechanism of action.
T1D Antibody Screening: Identifying High-Risk Populations
Following audience polls, the panelists provide clinical insights into their screening practices for patients with type 1 diabetes, highlighting key antibodies they screen for.
Engaging the Audience: Polling on Primary Populations and Community Perspectives in T1D Care
Audience polls provide the panel insights into common screening practices for patients with type 1 diabetes.
T1D Staging: The Clinical Importance of Early Recognition
The panel outlines the stages of type 1 diabetes, focusing on the importance of early intervention to prevent complications of the disease.
Navigating T1D: Mitigating Burden and Monitoring Disease Progression
A panel of experts on type 1 diabetes (T1D) describe the prevalence and burden of the disease, highlighting the emotional and socio-economic burden extending beyond medical expenses.
Optimizing Treatment: Expert Insights on Streamlining and Deprescribing for Older Adults with T2D
July 16th 2024Key opinion leaders explore methods for optimizing treatment in older adults with type 2 diabetes, focusing on streamlining regimens and the process of deprescribing, with particular emphasis on defining and implementing the deprescribing approach.
Insulin Therapy: Dosing Considerations, Injectable Options, and Tailoring for Glucose Control
July 16th 2024Leading experts in geriatric diabetes care explore comprehensive aspects of insulin therapy, including dosing strategies, available injectable options, and methods for tailoring glucose control in elderly patients.
Optimizing Geriatric Care: ADA Guidelines for Glycemic Goals and Long-Term Care Management
July 16th 2024Key opinion leaders explore strategies for enhancing elderly patient care by implementing American Diabetes Association guidelines on glycemic targets and long-term management in geriatric settings.
Integrating CGM Technology in Primary Care Diabetes Management: Key Takeaways and Practice Pearls
June 28th 2024The key opinion leaders explore strategies for incorporating continuous glucose monitoring into primary care diabetes management, highlighting essential takeaways from their comprehensive discussion.
Identifying Optimal Patient Groups for CGM Implementation
June 28th 2024The panelists discuss the selection criteria for continuous glucose monitoring (CGM) candidates, identifying patient groups who would derive the greatest benefit from CGM use and those at higher risk of complications without such monitoring.
Real-World CGM Case Study: Clinical Insights on Management and Impact
June 28th 2024Medical experts in diabetes management examine a real-world case study, providing valuable insights into the clinical impact of continuous glucose monitoring systems and their role in enhancing patient management strategies.
Tailored Diabetes Care: Customizing Management Strategies Across Life Stages
June 27th 2024Medha Munshi, MD, and Javier Morales, MD, FACP, FACE, emphasize the significance of personalized diabetes management, emphasizing age and other patient-specific factors as crucial considerations for optimizing care.
Key Insights and Practical Tips: Wisdom from UCSD Practitioners for Effective T1D Management
The panel of experts from UCSD concludes the discussion on delaying the onset of stage 3 T1D by providing key takeaways and clinical advice on the treatment of patients with this condition.